MaxCyte, Inc. (MXCT) Total liabilities 2020–2025
MaxCyte, Inc. (MXCT) total liabilities at each fiscal year-end, per SEC filings.
$31.0MFY2025 · since FY2020: $18.6M → $31.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $31.0M | -6.6% |
| FY2024 | $33.2M | -8.0% |
| FY2023 | $36.1M | +10.5% |
| FY2022 | $32.7M | +54.0% |
| FY2021 | $21.2M | +14.4% |
| FY2020 | $18.6M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More MXCT financial trends
MXCT RevenueMXCT Net incomeMXCT Net marginMXCT Gross profitMXCT Gross marginMXCT Operating incomeMXCT Operating marginMXCT Operating cash flowMXCT Free cash flowMXCT Capital expendituresMXCT Return on equityMXCT Stock buybacksMXCT Dividends paidMXCT Total assetsMXCT Shareholders’ equityMXCT overview →